CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation Long-term outcomes of rotational atherectomy of underexpanded stents. A single center experience Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer Pathophysiology, diagnosis and new therapeutic approaches for ischemic mitral regurgitation Patient and Hospital Characteristics of Mitral Valve Surgery in the United States

Original ResearchVolume 75, Issue 21, June 2020

JOURNAL:JACC Article Link

Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis

D Giacoppo, F Alfonso, B Xu et al. Keywords: DCB; DES; individual patient data; in-stent restenosis; restenosis

Full Text PDF